Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Key facts

Sponsor

National Cancer Institute (NCI)

Principal Investigator

Patrick A Brown

Children's Oncology Group

Intervention

Allogeneic Hematopoietic Stem Cell Transplantation(procedure)

Enrollment

669 enrolled

Eligibility

1-31 years · All sexes

Timeline

2014 – 2026

Study locations (30)

• Children's Hospital of Alabama, Birmingham, Alabama, United States
• USA Health Strada Patient Care Center, Mobile, Alabama, United States
• Providence Alaska Medical Center, Anchorage, Alaska, United States
• Banner Children's at Desert, Mesa, Arizona, United States
• Phoenix Childrens Hospital, Phoenix, Arizona, United States
• Banner University Medical Center - Tucson, Tucson, Arizona, United States
• Arkansas Children's Hospital, Little Rock, Arkansas, United States
• Kaiser Permanente Downey Medical Center, Downey, California, United States
• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• Loma Linda University Medical Center, Loma Linda, California, United States
• Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States
• Children's Hospital Los Angeles, Los Angeles, California, United States
• Cedars Sinai Medical Center, Los Angeles, California, United States
• Mattel Children's Hospital UCLA, Los Angeles, California, United States
• Valley Children's Hospital, Madera, California, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT07328503
  CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University

See all trials for Acute lymphoblastic leukemia →